Yohimbe, derived from the bark of the African tree *Pausinystalia yohimbe*, has been promoted as a natural remedy for erectile dysfunction (ED). Its active compound, yohimbine, affects the nervous system and has been studied for potential benefits in sexual function. However, yohimbe is not licensed as a medicine in the UK, and yohimbe bark is not permitted in food supplements in Great Britain. This article examines how yohimbe is claimed to work for ED, reviews the evidence, discusses safety concerns, and outlines safer, evidence-based alternatives available through the NHS.

What Is Yohimbe and How Does It Work for Erectile Dysfunction?

Yohimbe is a herbal product derived from the bark of Pausinystalia yohimbe, a tree native to Central and West Africa. It has been used traditionally as an aphrodisiac and has attracted interest as a potential treatment for erectile dysfunction (ED). The active compound in yohimbe bark is yohimbine, an alkaloid that affects the nervous system and cardiovascular function.

Yohimbine works primarily as an alpha-2 adrenergic receptor antagonist. By blocking presynaptic alpha-2 receptors, it increases the release of noradrenaline (norepinephrine) in the central nervous system and peripherally. This mechanism is thought to enhance sexual arousal through central nervous system pathways. However, increased noradrenaline activity also raises sympathetic nervous system activity, which can lead to elevated blood pressure and heart rate. Yohimbine does not act as a direct vasodilator in penile tissue in the way that phosphodiesterase-5 (PDE5) inhibitors such as sildenafil (Viagra) do. The relationship between yohimbine's pharmacological actions and improved erectile function remains incompletely understood and is not straightforward.

It is important to distinguish between yohimbe bark extract (a herbal product) and yohimbine hydrochloride, a pharmaceutical preparation that was studied more rigorously in the past. Yohimbine hydrochloride was occasionally prescribed for ED before the introduction of PDE5 inhibitors, but it is not licensed in the UK for this indication. Yohimbe bark products available online or from non-UK sources vary widely in their yohimbine content, purity, and safety, raising significant concerns.

UK regulatory status: Yohimbine is not licensed as a medicine for erectile dysfunction in the UK. Furthermore, yohimbe bark is not permitted in food supplements in Great Britain under current Food Standards Agency (FSA) regulations. Products marketed as yohimbe supplements may be illegally supplied, unregulated, and of uncertain quality. Men should be aware that purchasing such products online carries risks, including exposure to mislabelled, contaminated, or adulterated substances.

Evidence for Yohimbe in Treating Erectile Dysfunction

The evidence supporting yohimbe for erectile dysfunction is limited, of variable quality, and not sufficient to support its use. Most clinical studies have focused on yohimbine hydrochloride rather than yohimbe bark extract, and the quality of available research is generally poor.

A systematic review and meta-analysis by Ernst and Pittler, published in the Journal of Urology in 1998, suggested that yohimbine hydrochloride was superior to placebo for treating ED, particularly in cases of psychogenic erectile dysfunction (ED related to psychological rather than physical causes). However, the effect sizes were modest, and many of the included studies had significant methodological limitations, including small sample sizes, lack of standardisation, and inadequate blinding. More recent evidence has not strengthened the case for yohimbine.

Yohimbine is not recommended in current NICE Clinical Knowledge Summaries (CKS) on Erectile Dysfunction, which favour PDE5 inhibitors as first-line pharmacological treatment due to their superior efficacy, safety profile, and robust evidence base. The European Association of Urology (EAU) Guidelines on Male Sexual Dysfunction similarly do not endorse yohimbe or yohimbine as a standard treatment option.

A further challenge in evaluating yohimbe supplements is the variability and unreliability of product composition. Studies published in journals such as JAMA Internal Medicine have shown that over-the-counter yohimbe products often contain inconsistent amounts of yohimbine, and some are contaminated with undeclared pharmaceutical ingredients or other substances. This makes it impossible to draw firm conclusions about efficacy or safety from the available literature.

Overall, while there is some historical and anecdotal support for yohimbine in treating mild to moderate ED, robust, high-quality evidence is lacking. Men considering yohimbe should be aware that it is not a proven, licensed, or guideline-recommended treatment in the UK, and no reliable link has been established between yohimbe supplementation and consistent improvement in erectile function.

How to Use Yohimbe Safely for Erectile Dysfunction

Yohimbe is not a licensed medicine in the UK and yohimbe bark is not permitted in food supplements in Great Britain. Products marketed as yohimbe supplements are likely to be illegally supplied, unregulated, and of uncertain quality and safety. For these reasons, yohimbe cannot be recommended, and men should not attempt to self-medicate with such products.

Historically, clinical studies of yohimbine hydrochloride used doses ranging from 5 to 10 mg taken two to three times daily. However, these were research doses of a pharmaceutical preparation, not guidance for self-treatment. Over-the-counter yohimbe bark products do not specify exact yohimbine content, making accurate and safe dosing impossible. Pharmacological effects of yohimbine occur within hours of a dose, but clinical trials typically assessed outcomes over several weeks of regular use.

If a man is considering or has already obtained yohimbe, it is essential to:

• Consult a GP or healthcare professional urgently before use, particularly if there are underlying health conditions or other medications are being taken.

• Avoid yohimbe entirely if there is a history of cardiovascular disease, hypertension, kidney or liver disease, psychiatric disorders (especially anxiety or depression), gastric ulcers, or prostate problems, as yohimbine can worsen these conditions.

• Check for potential drug interactions. Yohimbe should not be taken with:

• Monoamine oxidase inhibitors (MAOIs)
• Tricyclic antidepressants (TCAs)
• Selective serotonin or serotonin-noradrenaline reuptake inhibitors (SSRIs/SNRIs) — use with caution and only under medical supervision
• Sympathomimetic drugs (e.g., decongestants such as pseudoephedrine)
• Stimulants, including caffeine in large amounts
• Clonidine or other antihypertensive medications
• PDE5 inhibitors (e.g., sildenafil, tadalafil) — combining these without medical advice may increase the risk of adverse effects

Yohimbe should be discontinued immediately if side effects occur, and medical advice should be sought. Given the lack of evidence, the absence of UK regulatory approval, and the availability of safer, evidence-based alternatives, yohimbe is not advisable for men with erectile dysfunction.

Side Effects and Risks of Yohimbe

Yohimbe and yohimbine are associated with a range of potential side effects, some of which can be serious. The side effect profile is a key reason why yohimbine is no longer used in clinical practice in the UK and why yohimbe products are not recommended by UK health authorities. The Medicines and Healthcare products Regulatory Agency (MHRA) has issued warnings about unlicensed 'herbal' sexual enhancement products, including those containing yohimbe or yohimbine, due to safety concerns.

Common side effects include:

• Anxiety, nervousness, and restlessness

• Insomnia and sleep disturbances

• Increased heart rate (tachycardia)

• Elevated blood pressure (hypertension)

• Dizziness and headache

• Gastrointestinal upset, including nausea and abdominal discomfort

• Tremor and sweating

More serious adverse effects can occur, particularly at higher doses, in susceptible individuals, or with contaminated/adulterated products. These include:

• Severe hypertension, which may lead to stroke or cardiovascular events

• Cardiac arrhythmias (irregular heartbeats)

• Panic attacks and worsening of anxiety or mood disorders

• Renal (kidney) toxicity (rare, often associated with overdose or contaminated products)

• Seizures (rare but reported in case studies)

Yohimbe is contraindicated in men with pre-existing cardiovascular disease, psychiatric conditions (especially anxiety, depression, or psychosis), renal or hepatic impairment, and those taking medications listed in the previous section.

When to seek medical help:

Men taking yohimbe should call 999 or go to A&E immediately if they experience chest pain, severe headache, palpitations, shortness of breath, signs of stroke (sudden weakness, speech difficulty, facial drooping), or seizures. For less urgent but concerning symptoms (e.g., persistent anxiety, tremor, or gastrointestinal upset), contact a GP promptly.

Reporting side effects:

If you suspect you have experienced a side effect from yohimbe or any other medicine or supplement, please report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or by downloading the Yellow Card app. Reporting helps improve the safety of medicines for everyone.

Given the potential risks and the availability of safer, evidence-based alternatives, yohimbe is not advisable for men with erectile dysfunction.

Alternatives to Yohimbe for Erectile Dysfunction in the UK

Men experiencing erectile dysfunction in the UK have access to a range of safe, effective, and evidence-based treatments that are recommended by NICE and widely available through the NHS and private healthcare.

First-line pharmacological treatments include PDE5 inhibitors, which are the gold standard for ED management:

• Sildenafil (Viagra and generics)

• Tadalafil (Cialis and generics)

• Vardenafil (Levitra and generics)

• Avanafil (Spedra)

These medications work by enhancing the natural erectile response to sexual stimulation by increasing blood flow to the penis. They are well-tolerated, have a strong evidence base, and are available on NHS prescription for men with certain underlying conditions (e.g., diabetes, prostate cancer treatment, severe distress). Generic sildenafil may be prescribed on the NHS at GP discretion. Sildenafil 50 mg (Viagra Connect) is also available as a Pharmacy (P) medicine in the UK, meaning it can be supplied by a pharmacist after a consultation, without a prescription.

Non-pharmacological approaches are also important and may be recommended alongside or instead of medication:

• Lifestyle modifications: Weight loss, regular exercise, smoking cessation, and reducing alcohol intake can significantly improve erectile function and overall cardiovascular health.

• Psychological therapy: Cognitive behavioural therapy (CBT) or psychosexual counselling may be beneficial, particularly for psychogenic ED or when relationship issues are contributing factors.

• Vacuum erection devices: Mechanical devices that draw blood into the penis to create an erection.

• Intracavernosal or intraurethral alprostadil: Injectable or pellet formulations for men who do not respond to oral medications.

• Penile prosthesis surgery: A later-line option for men with refractory ED.

For men with underlying health conditions such as diabetes, hypertension, or cardiovascular disease, optimising management of these conditions is essential and may improve erectile function.

Initial assessment and investigations:

When a man presents with ED, a GP will typically:

• Take a full medical, sexual, and psychosocial history

• Assess cardiovascular risk factors

• Check blood pressure

• Arrange blood tests, including fasting glucose or HbA1c (to screen for diabetes), lipid profile, and morning total testosterone if there are features of low libido or possible hypogonadism

When to see a GP:

Men experiencing persistent erectile dysfunction should consult their GP for a thorough assessment. ED can be an early warning sign of cardiovascular disease, diabetes, or other health problems. A healthcare professional can identify underlying causes, discuss treatment options, and provide a personalised, safe, and effective management plan.

When to refer:

Referral to a specialist (urology, endocrinology, or sexual health) may be appropriate if:

• ED persists despite first-line treatment

• There are signs of hypogonadism or other endocrine abnormalities

• Peyronie's disease or other structural penile abnormalities are present

• Significant psychosexual or relationship issues require specialist input

For more information, see NICE Clinical Knowledge Summaries: Erectile Dysfunction and the NHS website: Erectile dysfunction.

Frequently Asked Questions